Moon Surgical Secures FDA Approval for ScoPilot, Revolutionizing AI in Surgical Robotics

Innovation in Surgery: Moon Surgical's Breakthrough

Moon Surgical, a leading innovator in surgical technology, has made headlines with the FDA's recent approval of its groundbreaking product, ScoPilot™. This state-of-the-art intraoperative assistant is powered by NVIDIA Holoscan, a cutting-edge platform designed to support AI applications in the operating room, and is seamlessly integrated into the Maestro™ system. This marks a significant milestone as ScoPilot becomes the first AI application to operate within a commercial surgical robotics platform during surgeries.

What is ScoPilot?

ScoPilot is not just a piece of technology; it represents a paradigm shift in how surgeries are performed. It ensures a stable, optimized view throughout surgery, enhancing controllability, safety, and efficiency in the operating room. What sets ScoPilot apart is its intuitive functionality, which can be activated on demand. It allows the laparoscope, mounted on the Maestro system, to automatically follow the end of a selected surgical instrument controlled by the surgeon. This innovative approach enables surgeons to maintain instrument control without the need to release their tools, resulting in a smoother and more focused surgical experience.

Anne Osdoit, the CEO of Moon Surgical, emphasizes the remarkable advantages of ScoPilot, stating, "With ScoPilot, surgeons can manage three instruments with just two hands while ensuring a continuously stable and optimal field of vision—this is crucial in surgery." The control provided by ScoPilot is set to enhance surgical efficiency, making surgeons more autonomous while elevating their visual capabilities during procedures.

The Maestro System: A Game Changer

The Maestro system itself received FDA clearance in June 2024 and has since been utilized for over 1,100 patient procedures across the United States and Europe, addressing various surgical needs ranging from general and digestive surgery to bariatric, gynecological, and urological surgeries. The Maestro system distinguishes itself with its unique environmental perception capabilities, enabled by the computational power and AI features of NVIDIA. This technology generates unprecedented surgical data sets, including multimodal perception and instrument kinematics, aiding the development of advanced 'Physical AI' capabilities aimed at improving surgical care both intraoperatively and throughout the perioperative journey.

Kimberly Powell, Vice President of Healthcare at NVIDIA, praises Moon Surgical’s achievements, saying, "The digital platform of Moon Surgical, built on NVIDIA Holoscan, has been a true catalyst, leading to a continuous stream of groundbreaking advancements in the surgical robotics industry. With ScoPilot, Moon Surgical has accomplished an unprecedented feat by obtaining FDA approval for AI-driven surgical motion integrated natively within a robotic platform powered by Holoscan."

The Future of Surgery with Moon Surgical

Moon Surgical, headquartered in both Paris and San Francisco, is dedicated to shaping the operating rooms of the future into efficient, digitalized, and sustainable environments. The combination of the Maestro system and the intelligent platform Maestro Insights empowers healthcare teams to make informed decisions and optimize surgical care for their patients. Since its inception in 2020, Moon Surgical has stood out for its agility, commitment to innovation, and an inclusive culture that fosters creativity and collaboration within its multicultural team.

As we look towards the future, Moon Surgical’s goal remains clear: to inspire and innovate the art of surgery. For further information about their revolutionary technologies, visit their website at moonsurgical.com or follow them on LinkedIn.

Moon Surgical Technology